X4 Pharmaceuticals (XFOR) EPS (Basic) (2017 - 2026)
X4 Pharmaceuticals' (XFOR) quarterly EPS (Basic) came in at -$0.57 in Q4 2025, up 90.49% YoY from -$0.3 in Q4 2024, and up 17.87% on a QoQ basis from -$0.69 in Q3 2025.
X4 Pharmaceuticals (XFOR) EPS (Basic) (2017 - 2026) Analysis & Trends
X4 Pharmaceuticals (XFOR) has 9 years of EPS (Basic) data on file, last reported at -$0.57 in Q4 2025.
- Quarterly EPS (Basic) rose 90.49% year-over-year to -$0.57 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.87 (up 66.5% YoY) and the FY2025 annual result came in at -$1.87, up 66.54% from the prior year.
- EPS (Basic) climbed to -$0.57 in Q4 2025, from -$0.69 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $13.6 in Q2 2024 to a low of -$41.84 in Q4 2021.
- A 5-year average of -$10.78 and a median of -$6.86 in 2024 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 237.24% in 2024, down 1459.37% in 2024.
- Tracing XFOR's EPS (Basic) over 5 years: stood at -$41.84 in 2021, then surged by 67.15% to -$13.75 in 2022, then soared by 76.52% to -$3.23 in 2023, then plunged by 84.13% to -$5.94 in 2024, then jumped by 90.49% to -$0.57 in 2025.
- The last three EPS (Basic) figures came in at -$0.57 (Q4 2025), -$0.69 (Q3 2025), and -$3.47 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | -0.69 |
| Jun 30, 2025 | -3.47 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -5.94 |
| Sep 30, 2024 | -5.47 |
| Jun 30, 2024 | 13.60 |
| Mar 31, 2024 | -7.77 |
| Dec 31, 2023 | -3.23 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -9.91 |
| Mar 31, 2023 | -4.94 |
| Dec 31, 2022 | -13.75 |
| Sep 30, 2022 | -7.89 |
| Jun 30, 2022 | -17.96 |
| Mar 31, 2022 | -21.54 |
| Dec 31, 2021 | -41.84 |
| Sep 30, 2021 | -22.75 |
| Jun 30, 2021 | -22.21 |